Expert Insight Why FDA’s CRL wave isn’t a CMC crisis — and what biotechs should do instead 3 March 2026
Expert Insight China’s Biotech Ascent Reshapes Global Pharma Strategy, Dominates JPM26 Discussions 19 January 2026
Podcast Building Investor-Ready CMC Programs: Marta Kijanka’s Strategic Framework for Early-Stage Biotechs 20 October 2025
Category Guide Biotech Manufacturing Strategy: Key Questions Investors Ask & Why They Matter 20 January 2025
CDMO Live Spotlight You’ve Got Funding, Now What? A 90 Day Plan for Initiating Drug Development 1 July 2024
Podcast How to Navigate Contract Manufacturing in Biotech: Interview with Bernardo Estupiñán 22 February 2024